Accelerating Precision Oncology

With the power of data and AI to make effective treatment decisions.

Empowering Precision Oncology through Dynamic Data Analytics.

Identify target drugs for advanced cancers through comprehensive tumor genomics.

Liquid biopsy (blood) work-up for scenarios where tissue biopsy is unavailable.

Blood-based monitoring to evaluate cancer progression and response to treatment.

Clinically correlated and well-referenced dynamic lab report for better cancer care

AI-powered digital pathology to enhance treatment decisions and reduce turnaround time

Multi-omics on single CTCs to predict tumor behaviour and risk of recurrence 

Tests and Services

What we offer

OncoIndx: Genomic Profiling Test

Comprehensive 1000+ gene panel to detect genomic alterations for actionable insights with AI/ ML-enabled dynamic data analysis via NGS for both liquid and tissues biopsies, including CTC evaluation.

OncoDiscover: CTC Blood Test

India's first indigenously developed, patented in-vitro diagnostic test to detect, capture and enumerate Circulating Tumor Cells - telltale signature of cancer metastasis, using very low volume of blood.

OncoMonitor: A Novel Liquid Biopsy Test

A Novel Liquid Biopsy Test for Long-term Disease Monitoring & Minimal ResidualDisease Detection for Cancer Management

OncoRisk: A Germline Test

A Hereditary Germline cancer test that represents a robust solution, examining a comprehensive panel of 74 genes connected to a spectrum of more than 11 distinct Hereditary and Familial cancers.

OncoTarget: Targeted NGS Panel

A cutting-edge NGS Panel designed to identify targeted mutations in Bladder, Breast, Colon, GI, Lung, Melanoma, Ovary, Prostate, Rectal, and Thyroid.

OncoPredikt: AI-powered Digital Pathology

An AI-based toolkit that predicts key genomic signatures from H&E whole slide images(WSI) to identify potential patients to benefit from Immunotherapy, Platinum base treatment, and PARP inhibitor therapy.

iCare: Cancer Management Application

A dynamic cancer management application with an easy-to-use UI, enabling clinicians to assess disease progression and treatment courses for each patient in a personalised approach.

iDiscover: Interactive Tool for Research

iDiscover – a powerful tool that give a birds eye view of the data available in the study. This tool allows users to further slice and dice your data to observe trends and create groups of interest.

Redefining the Future of Precision Oncology

Incredible Technology backed by Incredible Science

Our Precision Oncology Platform.
Pioneering the future of cancer care with the power of AI / ML and data.

A revolutionary informatics platform offering an integrated ecosystem for managing data-intensive and biomarker-rich precision medicine clinical trial.

  • Real-time data access with Open API

  • Rapid Translation of Biological Data

  • Cross Study Profiling and Interrogation

  • Data-Driven Patient Stratification

  • High security with advanced encryption

  • Improved Patient Outcome

Creating a 360º impact!

OneCell Diagnostics

Now experience the future of data-driven cancer care with OneCell Diagnostics - the world's only clinical laboratory to unite tumor genomics, CTC analytics, single-cell multi-omics, AI, and dynamic data analytics in digital molecular pathology, providing a truly comprehensive approach to precision oncology.

OneCell’s publications and presentations have been widely acclaimed across world’s leading oncology platforms.

Our Science

Lab on Chip

Smriti Arora, Alain D'Souza, Gourishankar Aland, Narendra Kale, Bhagwat Jadhav, Trupti Kad, Pankaj Chaturvedi, Balram Singh, Jayant Khandare. Antibody mediated cotton-archetypal substrate for enumeration of circulating tumor cells and chemotherapy outcome in 3D tumors. Lab on a Chip; 2022; 22 (8); 1519-1530

Journal of Clinical Oncology

Gowhar Shafi, Shivamurthy P M, Anand Ulle, Krithika Srinivasan, Aravindan Vasudevan, Vikas Jadhav, Dr Sujit Joshi, Nirmal Vivek Raut, Jayant Khandare, Mohan Uttarwar, Kenneth Joel Bloom. AI-enabled identification prediction of homologous recombination deficiency (HRD) from histopathology images. Journal of Clinical Oncology; 2022; 40; 3019-3019.

Strategic Partnerships to provide the best-in-class.
Our prominent partners from both academia and industries:


Some of our esteemed clients:

For partnership and product enquiries please reach out us. Click here.

“The team at OneCell made the entire experience very smooth and positive. Their results are accurate and on time. I highly recommend OneCell Diagnostics to anyone facing cancer.”

— Mrs Meena Khullar, Delhi